TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $69,781 | -62.5% | 8,347 | +11.4% | 0.00% | -55.6% |
| Q2 2023 | $186,151 | +71.7% | 7,494 | +4.0% | 0.01% | +50.0% |
| Q1 2023 | $108,408 | +14.1% | 7,208 | -10.2% | 0.01% | +50.0% |
| Q4 2022 | $94,983 | +99.8% | 8,029 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $47,532 | +79.3% | 8,029 | +28.7% | 0.00% | +100.0% |
| Q2 2022 | $26,516 | -67.7% | 6,239 | -27.7% | 0.00% | -66.7% |
| Q1 2022 | $82,033 | -87.7% | 8,626 | -75.4% | 0.00% | -66.7% |
| Q4 2021 | $666,311 | -42.9% | 35,069 | 0.0% | 0.01% | -47.1% |
| Q3 2021 | $1,167,096 | -13.1% | 35,069 | +1.3% | 0.02% | -10.5% |
| Q2 2021 | $1,343,530 | -14.0% | 34,636 | +6.8% | 0.02% | -17.4% |
| Q1 2021 | $1,562,740 | -6.6% | 32,422 | +0.8% | 0.02% | -8.0% |
| Q4 2020 | $1,673,587 | +94.4% | 32,172 | 0.0% | 0.02% | +66.7% |
| Q3 2020 | $860,923 | +48.9% | 32,172 | +8.4% | 0.02% | +50.0% |
| Q2 2020 | $578,303 | +112.1% | 29,687 | +7.2% | 0.01% | +66.7% |
| Q1 2020 | $272,598 | -4.9% | 27,703 | +7.2% | 0.01% | +20.0% |
| Q4 2019 | $286,791 | +87.2% | 25,837 | -5.3% | 0.01% | +66.7% |
| Q3 2019 | $153,228 | -17.8% | 27,289 | +26.6% | 0.00% | 0.0% |
| Q2 2019 | $186,415 | +30.4% | 21,551 | +21.2% | 0.00% | 0.0% |
| Q1 2019 | $142,959 | +74.6% | 17,781 | -11.0% | 0.00% | +50.0% |
| Q4 2018 | $81,893 | -26.8% | 19,974 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $111,854 | -100.0% | 19,974 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $262,658,000 | +13.1% | 19,974 | +22.1% | 0.00% | +33.3% |
| Q1 2018 | $232,284,000 | +173246.3% | 16,358 | 0.0% | 0.00% | +50.0% |
| Q4 2017 | $134,000 | -62.6% | 16,358 | -45.9% | 0.00% | 0.0% |
| Q3 2017 | $358,000 | +17.8% | 30,247 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $304,000 | -13.6% | 30,247 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $352,000 | +72.5% | 30,247 | +14.7% | 0.00% | +100.0% |
| Q3 2016 | $204,000 | +32.5% | 26,377 | +3.7% | 0.00% | 0.0% |
| Q2 2016 | $154,000 | -29.0% | 25,432 | 0.0% | 0.00% | -50.0% |
| Q1 2016 | $217,000 | -28.4% | 25,432 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $303,000 | +18.4% | 25,432 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $256,000 | -39.3% | 25,432 | 0.0% | 0.00% | -33.3% |
| Q2 2015 | $422,000 | +40.2% | 25,432 | +30.8% | 0.00% | +50.0% |
| Q1 2015 | $301,000 | -2.3% | 19,448 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $308,000 | +48.1% | 19,448 | 0.0% | 0.00% | +100.0% |
| Q3 2014 | $208,000 | +13.7% | 19,448 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $183,000 | – | 19,448 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |